XCOPRI Trademark

Trademark Overview


On Friday, June 21, 2019, a trademark application was filed for XCOPRI with the United States Patent and Trademark Office. The USPTO has given the XCOPRI trademark a serial number of 88484180. The federal status of this trademark filing is REGISTERED as of Tuesday, August 11, 2020. This trademark is owned by SK BIOPHARMACEUTICALS CO., LTD.. The XCOPRI trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes and veterinary preparations for treatment of central nervous system diseases, cancer and metabolic diseases; biochemical preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for pharmaceutical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; medical preparation of trace elements for human and animal use, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; biotechnological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medicinal purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medical or veterinary purposes, namely, for the treatment of central nervous system diseases, cancer and metabo...
xcopri

General Information


Serial Number88484180
Word MarkXCOPRI
Filing DateFriday, June 21, 2019
Status700 - REGISTERED
Status DateTuesday, August 11, 2020
Registration Number6125911
Registration DateTuesday, August 11, 2020
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 11, 2020

Trademark Statements


Description of MarkThe mark consists of the stylized word "XCOPRI" in purple upper case letters. The letter "O" contains a red circular design divided by a triangular ray, which extends past the letter "O". The remaining color white represents background and is not a feature of the mark.
Goods and ServicesMedicines for human purposes and veterinary preparations for treatment of central nervous system diseases, cancer and metabolic diseases; biochemical preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for pharmaceutical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; medical preparation of trace elements for human and animal use, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; biotechnological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medicinal purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medical or veterinary purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; pharmaceutical preparations for immunity adjustment; therapeutic drugs and agents for the treatment of central nervous system diseases, cancer and metabolic diseases; chemico-pharmaceutical preparations for the treatment of central nervous system diseases, cancer and metabolic diseases
Indication of Colors claimedThe colors purple and red are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 2, 2019
Primary Code005
First Use Anywhere DateMonday, May 11, 2020
First Use In Commerce DateMonday, May 11, 2020

Trademark Owner History


Party NameSK BIOPHARMACEUTICALS CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeongnam-si 13494
KR

Party NameSK BIOPHARMACEUTICALS CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeongnam-si 13494
KR

Party NameSK BIOPHARMACEUTICALS CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeongnam-si 13494
KR

Trademark Events


Event DateEvent Description
Thursday, September 12, 2019ASSIGNED TO EXAMINER
Tuesday, June 25, 2019NEW APPLICATION ENTERED
Tuesday, July 2, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 3, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, September 16, 2019SUSPENSION LETTER WRITTEN
Monday, September 16, 2019LETTER OF SUSPENSION E-MAILED
Monday, September 16, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, October 7, 2019ASSIGNED TO EXAMINER
Wednesday, November 27, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, December 11, 2019ASSIGNED TO LIE
Tuesday, February 11, 2020PUBLISHED FOR OPPOSITION
Friday, December 6, 2019ASSIGNED TO LIE
Monday, December 23, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 23, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 2, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 7, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 11, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, May 11, 2020USE AMENDMENT FILED
Monday, July 6, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 11, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, November 27, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 27, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 27, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, May 11, 2020TEAS STATEMENT OF USE RECEIVED
Thursday, May 28, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 28, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 7, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, November 27, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 11, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED